Julie DiCarlo

Keine laufenden Positionen mehr

Health Technology

Consumer Services

Ehemalige bekannte Positionen von Julie DiCarlo

Unternehmen	Position	Beginn	Ende
AKILI, INC.	Public Communications Contact	01.09.2019	-
PURETECH HEALTH PLC	Investor Relations Kontakt	-	-
PURETECH HEALTH PLC	Public Communications Contact	-	-
EPIZYME, INC.	Investor Relations Kontakt	02.08.2016	-
EPIZYME, INC.	Public Communications Contact	02.08.2016	-
CUBIST PHARMACEUTICALS INC	Public Communications Contact	-	-

Towson University

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Public Communications Contact	4
Investor Relations Contact	2
Undergraduate Degree	1

Sektoral

Health Technology	5
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
PURETECH HEALTH PLC	Health Technology
AKILI, INC.	Health Technology

Private Unternehmen	2
Cubist Pharmaceuticals LLC Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA.	Health Technology
Epizyme, Inc. Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.	Health Technology

Private Unternehmen

Health Technology